155 related articles for article (PubMed ID: 21184646)
1. Functional drug screening assay reveals potential glioma therapeutics.
Badr CE; Wurdinger T; Tannous BA
Assay Drug Dev Technol; 2011 Jun; 9(3):281-9. PubMed ID: 21184646
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Gaussia luciferase blood assay for monitoring of in vivo biological processes.
Bovenberg MS; Degeling MH; Tannous BA
Anal Chem; 2012 Jan; 84(2):1189-92. PubMed ID: 22148161
[TBL] [Abstract][Full Text] [Related]
3. A secreted luciferase for ex vivo monitoring of in vivo processes.
Wurdinger T; Badr C; Pike L; de Kleine R; Weissleder R; Breakefield XO; Tannous BA
Nat Methods; 2008 Feb; 5(2):171-3. PubMed ID: 18204457
[TBL] [Abstract][Full Text] [Related]
4. Cell-based bioluminescence screening assays.
Amante RJ; Badr CE
Methods Mol Biol; 2014; 1098():185-95. PubMed ID: 24166378
[TBL] [Abstract][Full Text] [Related]
5. Large-Scale Drug Screening in Patient-Derived IDH
Dao Trong P; Jungwirth G; Yu T; Pusch S; Unterberg A; Herold-Mende C; Warta R
Cells; 2020 Jun; 9(6):. PubMed ID: 32503220
[TBL] [Abstract][Full Text] [Related]
6. Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo.
Tannous BA
Nat Protoc; 2009; 4(4):582-91. PubMed ID: 19373229
[TBL] [Abstract][Full Text] [Related]
7. The MTS vs. the ATP assay for in vitro chemosensitivity testing of primary glioma tumour culture.
Dawson TP; Iyer RV; Lea RW; Roberts P; Harris E; Ashton K; Golash A; Davis CH
Neuropathol Appl Neurobiol; 2010 Oct; 36(6):564-7. PubMed ID: 20524989
[No Abstract] [Full Text] [Related]
8. Bioluminescence-based cytotoxicity assay for simultaneous evaluation of cell viability and membrane damage in human hepatoma HepG2 cells.
Uno K; Murotomi K; Kazuki Y; Oshimura M; Nakajima Y
Luminescence; 2018 May; 33(3):616-624. PubMed ID: 29424036
[TBL] [Abstract][Full Text] [Related]
9. Optical imaging of tumor cells in hollow fibers: evaluation of the antitumor activities of anticancer drugs and target validation.
Zhang GJ; Chen TB; Bednar B; Connolly BM; Hargreaves R; Sur C; Williams DL
Neoplasia; 2007 Aug; 9(8):652-61. PubMed ID: 17786184
[TBL] [Abstract][Full Text] [Related]
10. A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis.
Weinmann L; Wischhusen J; Demma MJ; Naumann U; Roth P; Dasmahapatra B; Weller M
Cell Death Differ; 2008 Apr; 15(4):718-29. PubMed ID: 18202704
[TBL] [Abstract][Full Text] [Related]
11. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.
Fulda S; Wick W; Weller M; Debatin KM
Nat Med; 2002 Aug; 8(8):808-15. PubMed ID: 12118245
[TBL] [Abstract][Full Text] [Related]
12. Bioluminescence and MR Imaging of the Safety and Efficacy of Vascular Disruption in Gliomas.
Folaron M; Seshadri M
Mol Imaging Biol; 2016 Dec; 18(6):860-869. PubMed ID: 27160251
[TBL] [Abstract][Full Text] [Related]
13. Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay.
Zhang Y; Byun Y; Ren YR; Liu JO; Laterra J; Pomper MG
Cancer Res; 2009 Jul; 69(14):5867-75. PubMed ID: 19567678
[TBL] [Abstract][Full Text] [Related]
14. Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases.
Chung E; Yamashita H; Au P; Tannous BA; Fukumura D; Jain RK
PLoS One; 2009 Dec; 4(12):e8316. PubMed ID: 20016816
[TBL] [Abstract][Full Text] [Related]
15. High Throughput Screening for Colorectal Cancer Specific Compounds.
Xie J; Wang C; Gore JC
Comb Chem High Throughput Screen; 2016; 19(3):180-8. PubMed ID: 26830359
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide in glioma cells.
Saitoh Y; Goto T; Puduvalli VK; Murakami M; Kochi M; Levin VA; Kyritsis AP; Ushio Y
Int J Oncol; 1999 Sep; 15(3):499-504. PubMed ID: 10427131
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of C2-ceramide antitumor activity by small interfering RNA on X chromosome-linked inhibitor of apoptosis protein in resistant human glioma cells.
Hatano M; Mizuno M; Yoshida J
J Neurosurg; 2004 Jul; 101(1):119-27. PubMed ID: 15255262
[TBL] [Abstract][Full Text] [Related]
18. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
[TBL] [Abstract][Full Text] [Related]
19. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
Daher A; de Groot J
Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
[TBL] [Abstract][Full Text] [Related]
20. Linarin sensitizes tumor necrosis factor-related apoptosis (TRAIL)-induced ligand-triggered apoptosis in human glioma cells and in xenograft nude mice.
Xu ZF; Sun XK; Lan Y; Han C; Zhang YD; Chen G
Biomed Pharmacother; 2017 Nov; 95():1607-1618. PubMed ID: 28950661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
